NCT05550961 is a clinical trial in NSCLC, sponsored by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano.

Who is sponsoring NCT05550961?

NCT05550961 is sponsored by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano.

What condition does NCT05550961 study?

NCT05550961 studies NSCLC, Cancer, Lung Cancer, Adenocarcinoma of Lung, Squamous Cell Lung Cancer.

Is NCT05550961 still recruiting?

NCT05550961 is currently recruiting now. Last updated 23 October 2023.

Last reviewed 2023-10-23 · How we verify

NCT05550961

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

APOLLO 11, Consortium of Italian Centers Involved in Treatment of Patients With Lung Cancer Treated With Innovative Therapies: Real World Data and Translational Reaserch

Recruiting now Last updated 23 October 2023

What this trial tests

trial in NSCLC in 1,200 participants. Currently enrolling.

Timeline

1 October 2022

Primary endpoint
1 October 2027

1 October 2032

Quick facts

Lead sponsor	Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	1,200
Start date	1 October 2022
Primary completion	1 October 2027
Estimated completion	1 October 2032
Sites	1 location across Italy

Conditions studied

NSCLC — all drugs for NSCLC →
Cancer — all drugs for Cancer →
Lung Cancer — all drugs for Lung Cancer →
Adenocarcinoma of Lung — all drugs for Adenocarcinoma of Lung →

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano — full company profile →

Who can join

18 and older, any sex, with NSCLC or Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

APOLLO 11 main aim is to build a strong Italian long-lasting lung cancer network (in around 48 Italian centres) on real world data and translational research by creating a decentralized long-term national database (settle locally in each centre) and a "virtual" multilevel biobank in each centre. Besides, APOLLO 11 will take advantage of the translational research joint effort with the credo "unity is strength".

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Decentralized Clinical Trials in Early Drug Development-A Framework Proposal.
Silva DJ, Nelson BE, Rodon J. · · 2024 · cited 2× · PMID 39219999 · DOI 10.36401/jipo-23-33
Decentralized Clinical Trials in Pediatrics: Is Italy Ready?
Paternuosto G, Flamigni A, Zanier M, Bonifacio B, et al · · 2025 · PMID 41095986 · DOI 10.3390/jcm14196906

Verify or expand the search:

Other recruiting trials for NSCLC

Currently open trials in the same condition.

NCT07479277 — Progel Platinum for Air Leak Reduction After VATS Lobectomy for NSCLC · NA · recruiting
NCT07323732 — A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Diseas · Phase 2 · recruiting
NCT07274813 — A Phase I Study to Evaluate the Safety, Tolerability, and PK of HLX37 in Advanced/Metastatic Solid Tumors · EARLY_PHASE1 · recruiting
NCT07325864 — Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site · recruiting
NCT07169552 — HC010 in First-line PD-L1 Positive Advanced NSCLC Patients · Phase 2 · recruiting

Other Fondazione IRCCS Istituto Nazionale dei Tumori, Milano trials

Trials by the same sponsor.

NCT06799624 — Prognostic Role of molEcular classiFication in Fertility-sparing treAtment of Endometrial canCEr · not yet recruiting
NCT07253402 — Microbiota-guided Radiotherapy for Head and Neck Cancer · recruiting
NCT06938724 — Omission of Local Therapies in Women Patients With HER2-positive or Triple-negative Breast Cancer · Phase 2 · recruiting
NCT06999824 — Revisiting the Concept of Nerve Sparing Radical Hysterectomy · not yet recruiting
NCT06986486 — Liver Transplantation for Unresectable Perihilar Cholangiocarcinoma · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05550961 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Last refreshed: 23 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05550961.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing